Structure-Activity Relationship (SAR) study of novel nucleoside A2A adenosine receptor antagonist as immune-oncology agents, International round table on Nucleosides, Nucleotides, and Nucleic acids (IRT). 스웨덴 스톡홀롬. 2022.08.28. [Travel award in IRT]
Admin │ 2022-11-01 HIT 614 |
---|
|
이전글 | Design, synthesis and biological evaluation of novel nucleoside A2A adenosine re... |
---|---|
다음글 | Design, synthesis and binding affinities of novel nucleoside A2A adenosine recep... |